Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Petar-Marko Spanjol"'
Autor:
Christian Kreis, Petar Marko Spanjol, Andrea Daniela Maier, Morten Ziebell, Ian Law, Lars Poulsgaard, Tina Nørgaard Munch, Martjin van Essen, Daniela A. Bota, Thomas Graillon, Asma Bashir, Christian Mirian, Lasse Rehné Jensen, Helle Broholm, Kåre Fugleholm, Maria Pedersen, Martin A. Walter, Anne Katrine Duun-Henriksen, Maya Hrachova, Tiit Mathiesen
Publikováno v:
Mirian, C, Duun-Henriksen, A K, Maier, A, Pedersen, M M, Jensen, L R, Bashir, A, Graillon, T, Hrachova, M, Bota, D, van Essen, M, Spanjol, P, Kreis, C, Law, I, Broholm, H, Poulsgaard, L, Fugleholm, K, Ziebell, M, Munch, T, Walter, M A & Mathiesen, T 2021, ' Somatostatin Receptor-Targeted Radiopeptide Therapy in Treatment-Refractory Meningioma : Individual Patient Data Meta-analysis ', Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol. 62, no. 4, pp. 507-513 . https://doi.org/10.2967/jnumed.120.249607
Somatostatin receptor (SSTR)-targeted peptide receptor radionuclide therapy (PRRT) represents a promising approach for treatment-refractory meningiomas. Methods: We performed an individual patient data meta-analysis, including all published data on m
Autor:
Maria Umlauft, Piotr Radojewski, Jan Beyersmann, Attila Kollár, Martin A. Walter, Nicolas Marincek, Rebecca A. Dumont, Philippe Brunner, Petar-Marko Spanjol, Jan Mueller-Brand, Markus Laimer, Helmut R. Maecke
Publikováno v:
Journal of Nuclear Medicine. 58:97-102
We aimed to assess the risk of developing diabetes mellitus and its effects on all-cause mortality after radiopeptide therapy for neuroendocrine tumors (NET). Methods: NET patients received somatostatin radiopeptide therapy with yttrium-90-DOTATOC an
Autor:
Ann-Catherine Jörg, Philippe Brunner, Anja Schmitt, Helmut R. Maecke, Aurel Perren, Nicolas Marincek, Rebecca A. Dumont, Petar Marko Spanjol, Katharina Glatz, Matthias Briel, Piotr Radojewski, Lukas Bubendorf, Jan Müller-Brand, Martin A. Walter, Thomas Krause, Maria Umlauft
Publikováno v:
Brunner, Philippe; Jörg, Ann-Catherine; Glatz, Katharina; Bubendorf, Lukas; Radojewski, Piotr; Umlauft, Maria; Marincek, Nicolas; Spanjol, Petar Marko; Krause, Thomas Michael; Dumont, Rebecca A; Maecke, Helmut R; Müller-Brand, Jan; Briel, Matthias; Schmitt, Anja; Perren, Aurel; Walter, Martin Alexander (2017). The prognostic and predictive value of sstr2-immunohistochemistry and sstr2-targeted imaging in neuroendocrine tumors. European journal of nuclear medicine and molecular imaging, 44(3), pp. 468-475. Springer 10.1007/s00259-016-3486-2
PURPOSE Our aim was to assess the prognostic and predictive value of somatostatin receptor 2 (sstr2) in neuroendocrine tumors (NETs). METHODS We established a tissue microarray and imaging database from NET patients that received sstr2-targeted radio
Autor:
Thomas Krause, Bernd Klaeser, Petar Marko Spanjol, George Prenosil, Sabine Edith Weidner, Markus Fürstner, Michael Hentschel
Purpose To determine the thyroid clearance effective half-life T with a common handheld electronic dosimeter (ED) in patients undergoing radioiodine treatment for hyperthyroidism. Methods Dose rates from 12 inpatients were measured daily with an ED a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c463f956513da9afce6c07605657b2d1
Autor:
Philippe, Brunner, Ann-Catherine, Jörg, Katharina, Glatz, Lukas, Bubendorf, Piotr, Radojewski, Maria, Umlauft, Nicolas, Marincek, Petar-Marko, Spanjol, Thomas, Krause, Rebecca A, Dumont, Helmut R, Maecke, Jan, Müller-Brand, Matthias, Briel, Anja, Schmitt, Aurel, Perren, Martin A, Walter
Publikováno v:
European journal of nuclear medicine and molecular imaging. 44(3)
Our aim was to assess the prognostic and predictive value of somatostatin receptor 2 (sstrWe established a tissue microarray and imaging database from NET patients that received sstrWe included a total of 279 patients. In these patients, sstrOur resu
Autor:
Piotr Radojewski, Maria Umlauft, Markus Laimer, Helmut R. Maecke, Petar Marko Spanjol, Philippe Brunner, Jan Beyersmann, Rebecca A. Dumont, Nicolas Marincek, Jan Müller-Brand, Attila Kollár, Martin A. Walter
Publikováno v:
Journal of Nuclear Medicine. 58:1532.1-1532
REPLY: We thank Drs. Pakzad and Safiri for their interest in our paper ([1][1]). We agree that there are a variety of methodologic questions to potentially be discussed ([2][2]–[4][3]), but we disagree with their criticism of our paper. First, they